Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US COVID-19 Claim Warnings Continue; Hi-Tech’s Problems Extend To Undeclared Allergens

Apr 12 2021

• By Malcolm Spicer

Related Content

As Hi-Tech Argues For DMHA Use, DMAA Seizure Falls In FDA's Criminal Case, Contempt Stands In FTC Complaint

Oct 02 2019

Defendant On Criminal Steroid Charges Owns Firm FDA Warns On Stimulant Found In Supplement

Jun 16 2020

Wheat, Hi-Tech Fined $40M For Violating Court Order On FTC Complaint

Oct 13 2017

Additional Topics

International United States US States Dietary Supplements FDA Coronavirus COVID-19 Advertising, Marketing & Sales Commercial Companies E-Commerce Enforcement Ingredients Legal Issues Manufacturing Policy Regulation Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window